WMCCP A.I CyberSecurity Scoring
04/12/2025
Access Monitoring Plan
Access Monitoring Plan
No incidents recorded for WVU Medicine Camden Clark Physicians in 2026.
No incidents recorded for WVU Medicine Camden Clark Physicians in 2026.
No incidents recorded for WVU Medicine Camden Clark Physicians in 2026.
A Rede D’Or é a maior rede de saúde da América Latina. São 79 hospitais e mais de 60 clínicas oncológicas com presença nos estados de AL, BA, CE, DF, MA, MG, MS, PA, PB, PE, PR, RJ, SE, SP. Referência em qualidade técnica, a Rede D’Or atua em serviços complementares como banco de sangue, diálise e ambulatórios de diversas especialidades. A Rede D’Or também investe em inovação e pesquisa clínica por meio do IDOR - Instituto D’Or de Pesquisa e Ensino. Siga a Rede D’Or também em: Instagram: @rededor_oficial Facebook: https://www.facebook.com/rededor YouTube: https://www.youtube.com/user/rededorsaoluiz
Since its beginning in 1902, Cedars-Sinai has evolved to meet the healthcare needs of one of the most diverse regions in the nation, continually setting new standards for quality and innovation in patient care, research, teaching and community service. Today, Cedars-Sinai is widely known for its national leadership in transforming healthcare for the benefit of patients. Cedars-Sinai receives consistent recognition for our excellence. Our awards include; being named one of America’s Best Hospitals by U.S. News & World Report, receiving the National Research Corporation’s Consumer Choice Award 19 years in a row for providing the highest-quality medical care in Los Angeles, achieving the longest-running Magnet designation for nursing excellence in California, and being recognized as The Advisory Board Company’s 2017 Workplace of the Year, an award Cedars-Sinai has won three years in a row. This annual award recognizes hospitals and health systems nationwide that have outstanding levels of employee engagement. Cedars-Sinai is a leader in the clinical care and research of heart disease, cancer and brain disorders, among other areas. Pioneering research achievements include using cardiac stem cells to repair damaged hearts, developing minimally invasive surgical techniques and discovering new types of drugs to target cancer more precisely. Cedars-Sinai also impacts the future of healthcare through education programs that encompass everything from highly competitive medical residency and fellowship programs to a biomedical science and translational medicine PhD program, advanced training for nurses and educational opportunities for allied health professionals. Most notably, Cedars-Sinai demonstrates a longstanding commitment to strengthening the Los Angeles community through wide-ranging programs that improve the health of its most vulnerable residents.
Penn Medicine is a world leader in academic medicine, setting the standard for cutting-edge research, compassionate patient care, and the education of future health care professionals. From founding the nation’s first hospital and medical school to pioneering Nobel Prize-winning mRNA vaccines and lifesaving cancer therapies, Penn Medicine continues to show the world what comes next. Home to more than 49,000 team members, Penn Medicine includes the University of Pennsylvania Health System and the Perelman School of Medicine. Together, our clinicians and scientists drive discoveries that transform patient care and improve lives across Pennsylvania, New Jersey, and beyond. Penn Medicine’s seven hospitals—the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Pennsylvania Hospital, Chester County Hospital, Lancaster General Health, Penn Medicine Princeton Health, and Doylestown Health—along with hundreds of outpatient sites and home care services, provide exceptional care throughout the region. At Penn Medicine, innovation and collaboration fuel everything we do. Our mission is to advance knowledge and improve health through research, patient care, and education in an inclusive culture that embraces diversity, fosters innovation, and sustains our legacy of excellence. Learn more: www.pennmedicine.org Read the latest stories: www.pennmedicine.org/news
Michigan Medicine, based in Ann Arbor, Michigan, is part of one of the world’s leading universities. Michigan Medicine is a premier, highly ranked academic medical center and award-winning health care system with state-of-the-art facilities. Our vision is to create the future of health care through scientific discovery, innovations in education, and the most effective and compassionate care. We want to be the leader in health care, health care reform, and biomedical innovation. Michigan Medicine includes the U-M Hospitals and Health Centers; the U-M Medical School and its Faculty Group Practice; one of the nation's largest biomedical research communities; and education programs that train thousands of future health professionals and scientists each year. We were formerly known as the University of Michigan Medical Center; today that term applies generally to the collection of buildings on our main medical campus in Ann Arbor. We have a close partnership with the U-M School of Nursing and other health sciences schools at U-M. Through the Michigan Health Corporation, we are able to form partnerships outside of our University.
Boston's Brigham and Women's Hospital (BWH) is an international leader in virtually every area of medicine and has been the site of pioneering breakthroughs that have improved lives around the world. A major teaching hospital of Harvard Medical School, BWH has a legacy of excellence that continues to grow. With two outstanding hospitals, over 150 outpatient practices, and over 1,200 physicians, we serve patients from New England, throughout the United States, and from 120 countries around the world. The BWH name is a reflection of our history. In 1980 three of Boston’s oldest and most prestigious Harvard Medical School teaching hospitals - the Peter Bent Brigham Hospital, the Robert Breck Brigham Hospital, and the Boston Hospital for Women – merged to form Brigham and Women’s Hospital. As a national leader in improving health care quality and safety, we have helped to develop some of the industry’s best practices including computerized physician order entry (CPOE) to prevent medication errors. The CPOE is now a nationally-accepted safety practice. The BWH Biomedical Research Institute (BRI) is one of the most powerful biomedical research institutes in the world and the second largest recipient of National Institutes of Health (NIH) funding among independent hospitals in the United States. BWH has long had great success in research as measured by the number of important discoveries made, the size and scope of its research portfolio and the volume of publications annually. BWH is a training ground for physicians, nurses, and allied health professionals. We have 1,100 trainees in over 140 of the most sought after training programs in the world, and also host Harvard Medical School students in rotations throughout our programs. As our global health services expand, our clinical trainees have rich opportunities to contribute and learn in challenging environments around the world. Brigham and Women's Hospital is an EEO, AA, VEVRAA Employer.
Texas Children’s Hospital is a world-class pediatric facility, nationally recognized as a top children’s hospital, and voted one of the best places to work in Houston for nine years running. We’re committed to creating a healthy community for children by providing the best pediatric care possible, through groundbreaking research and emphasis on education. We also offer a full continuum of family-centered care for women, from obstetrics to well-woman care. As a team member at Texas Children’s Hospital, you’ll work in an environment that values your voice. Texas Children's Hospital, headquartered in Houston, Texas, is recognized as one of America's best children's hospitals.
Clear and confident health care decisions begin with questions. At Labcorp, we’re constantly in pursuit of answers. As a global leader of innovative and comprehensive laboratory services, we help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. Our more than 60,000 employees serve clients in over 100 countries, worked on over 80% of the new drugs approved by the FDA in 2022 and performed more than 600 million tests for patients around the world. Learn more about Labcorp (NYSE: LH) at www.labcorp.com.
With more than 170,000 staff and 228 hospitals, there are millions of ways we are enriching the health of the NSW community every day. In front of a patient, working in a kitchen, developing new treatments, or at a desk, each one of our staff is a vital member of the largest health organisation in Australia. What binds us is our shared passion and commitment to caring for people. We’re empowering staff to work to their full potential and equip people with skills and capabilities to be agile and responsive. Join the team enriching health in millions of ways every day. Find out more: https://www.health.nsw.gov.au/careers/Pages/benefits.aspx View our social media community guidelines here: https://www.health.nsw.gov.au/social/Pages/community-guidelines
Community Health Systems is one of the nation’s leading healthcare providers. Developing and operating healthcare delivery systems across 14 states, CHS is committed to helping people get well and live healthier. CHS affiliates operate 70 acute-care hospitals and more than 1,000 other sites of care, including physician practices, urgent care centers, freestanding emergency departments, occupational medicine clinics, imaging centers, cancer centers and ambulatory surgery centers.
Latest updates, reports, and threat intel affecting the global network.
MARIETTA — Washington State Community College changed its name to Washington State College of Ohio in December as part of its expanding...
MSI Radix AXE6600 router firmware version v781521 contains a command injection vulnerability in the wps.cgi interface that allows remote attackers to execute arbitrary commands by injecting malicious input through the pin2g, pin5g, or pin6g parameters. Attackers can exploit these unsanitized parameters to execute arbitrary commands on the affected device and obtain root privileges.
CTI-Transmute contains a stored cross-site scripting vulnerability caused by insufficient neutralization of Vue template expression delimiters in server-rendered user-controlled data. An unauthenticated attacker can create a public conversion whose name or description contains a malicious Vue expression using the application's configured [[ ... ]] delimiters. User profile names may provide an additional injection vector. Although Jinja HTML escaping is applied, the resulting value is subsequently included in a DOM region compiled by Vue. Vue interprets the attacker-controlled value as a template expression rather than ordinary text. By accessing the JavaScript Function constructor from within the expression, an attacker can execute arbitrary JavaScript in the security context of the CTI-Transmute origin. The application's nonce-based Content Security Policy does not prevent exploitation because the Vue runtime compiler requires the unsafe-eval policy exception. The malicious payload is stored by the application and executed whenever another user opens an affected page, such as the public conversion detail page. The victim may be a normal user or an administrator. Successful exploitation could allow the attacker to: * Access data available to the victim through the application. * Extract API keys, tokens, or other sensitive information exposed to the page. * Perform authenticated actions using the victim's session. * Modify conversions or other application data. * Escalate the impact by targeting an administrator. A demonstrated payload can use [].constructor.constructor(...) to obtain the JavaScript Function constructor and execute arbitrary code. The regression tests also show that a short first-stage payload could retrieve an uncapped conversion description and evaluate a larger second-stage payload. The patch addresses the vulnerability by registering a global Jinja finalize hook that inserts a zero-width Unicode word joiner inside every Vue delimiter found in server-rendered values. This prevents Vue from recognizing the values as template expressions while preserving their visible representation.
D-Link DWR-M961 devices with hardware version C1 and software version 1.1.2_C1_202602110044 contain a buffer overflow vulnerability in the quicksetup.cgi interface. A remote attacker can write overly long strings to the test4, ssid2, and username fields and execute arbitrary commands by crafting a specific payload, or cause the device to crash.
D-Link DWR-M961 devices with hardware version C1 and software version 1.1.2_C1_202602110044 contain a buffer overflow vulnerability in the app.cgi interface. A remote attacker can write an overly long string to the netAcc.addlist[].name field and execute arbitrary commands by crafting a specific payload, or cause the device to crash.
D-Link DWR-M961 devices with hardware version C1 and software version 1.1.2_C1_202602110044 contain a command injection vulnerability in the app.cgi interface. A remote attacker can inject arbitrary malicious commands into the netDig.ping.dst field, resulting in command execution with root privileges.
curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.